Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Blood magnesium decreased, Nausea, Vomiting
Clinical narrative: magnesium was a bit low; vomiting; Severe nausea/queasy; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD MAGNESIUM DECREASED (magnesium was a bit low), VOMITING (vomiting) and NAUSEA (Severe nausea/queasy) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced BLOOD MAGNESIUM DECREASED (magnesium was a bit low), VOMITING (vomiting) and NAUSEA (Severe nausea/queasy). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency; SODIUM CHLORIDE (intravenous) for Adverse event, at an unspecified dose and frequency; CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE (LACTATED RINGERS) for Adverse event, at an unspecified dose and frequency; MAGNESIUM OXIDE for Adverse event, at an unspecified dose and frequency and ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency. On 28-Mar-2021, BLOOD MAGNESIUM DECREASED (magnesium was a bit low) and VOMITING (vomiting) had resolved. At the time of the report, NAUSEA (Severe nausea/queasy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Company Comment: This case concerns a 23-year-old female patient with no details on relevant medical history, who experienced the unexpected non serious events of Nausea, Vomiting and the unexpected non serious event of Blood magnesium decreased after mRNA- 1273 Moderna vaccine. The onset of the events occurred aproximatedly 1 day after the first dose of mRNA- 1273 vaccine. Patient was observed in the emergency department for two to three hours, fluids and magnesium were replaced and ondansetron was given. The rechallenge is not applicable since only information about the first dose was disclosed. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Upon internal review on 16-Nov-2021, Company comment was added in the case.; Sender's Comments: This case concerns a 23-year-old female patient with no details on relevant medical history, who experienced the unexpected non serious events of Nausea, Vomiting and the unexpected non serious event of Blood magnesium decreased after mRNA- 1273 Moderna vaccine. The onset of the events occurred aproximatedly 1 day after the first dose of mRNA- 1273 vaccine. Patient was observed in the emergency department for two to three hours, fluids and magnesium were replaced and ondansetron was given. The rechallenge is not applicable since only information about the first dose was disclosed. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report